(Q44412196)

2 December 2017

title

Combination effect of AC-7700, a novel combretastatin A-4 derivative, and cisplatin against murine and human tumors in vivo (English)

1 reference

2 December 2017

1 reference

Yoshihiro Morinaga

1

1 reference

2 December 2017

Yasuyo Suga

2

1 reference

2 December 2017

Sumiko Ehara

3

1 reference

2 December 2017

Katsuhiro Harada

4

1 reference

2 December 2017

Yukio Nihei

5

1 reference

2 December 2017

Manabu Suzuki

6

1 reference

2 December 2017

publication date

1 February 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

94

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

200-204

1 reference

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01419.X

Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01419.X

A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01419.X

Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01419.X

In vitro antagonism between cisplatin and vinca alkaloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01419.X

Vinca alkaloids: anti-vascular effects in a murine tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01419.X

Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01419.X

Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration--time product.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01419.X

Preclinical evaluations of therapies combining the vascular targeting agent combretastatin A-4 disodium phosphate and conventional anticancer therapies in the treatment of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01419.X

Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01419.X

10.1111/J.1349-7006.2003.TB01419.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference